SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: fred hayes who wrote (9531)6/22/2006 7:04:15 PM
From: LJM  Respond to of 10280
 
Fred, I agree. What you are saying makes perfect sense.

Sorry you got caught holding. I dodged this bullet in March, but I have had my share of pain this year.. ENCY, DSCO. Still holding both for a "double ouch."

I need to hear more info re: indiplon next steps from FDA before I jump into this one again.

I still worry about the 15mg not approvable FDA language and I don't put much value on the lower doses.

Until then, this one is on the radar.



To: fred hayes who wrote (9531)6/22/2006 7:06:34 PM
From: Qualified Opinion  Read Replies (1) | Respond to of 10280
 
Fred, my guess is that Pfizer is dropping the Insomnia market.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News